Results 111 to 120 of about 12,682 (143)

Primary Biliary Cholangitis With Incomplete Response to Conventional Therapies But Had Complete Response to Baricitinib: A Case Report. [PDF]

Case Reports Hepatol
Kim GE, Imran M, Mostafa S, Kamel Y.
europepmc   +1 more source

Mechanisms of Cellular Responses of the Natural Alkaloid Caulerpin and Its Similarities with the Lipid-Lowering Agent Fenofibrate in <i>Mytilus galloprovincialis</i>. [PDF]

Toxins (Basel)
Panni M, Mezzelani M, Giuliani ME, Nisi Cerioni P, Nardi A, Mollo E, Regoli F, Benedetti M, Gorbi S.   +8 more
europepmc   +1 more source

Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor. [PDF]

Biomedicines
Jamal F, Elshaer A, Alatout MH, Odeh NB, Youssef A, Abo Abdullah H, Elmasry S, Shahin T, Abdul Nabi H, Worden AR, Malik TA, Lizaola-Mayo BC.   +11 more
europepmc   +1 more source

Chronic intermittent hypoxia increases Parkinson's disease susceptibility via PPARα-mediated lipid droplet-mitochondrial dysfunction. [PDF]

Theranostics
Zhai MR, Pan J, Wu ZH, He YY, Zhang KR, Ren L, Wang YR, Li YB, Gao J, Xiao L, Liu YH.   +10 more
europepmc   +1 more source

Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes. [PDF]

Clin Med Insights Endocrinol Diabetes
Abdul Wahab R, Wan Mahmood WA.
europepmc   +1 more source

Trends in utilization and cost of triglyceride-lowering therapies among Medicare beneficiaries: An analysis from the Medicare part D database. [PDF]

Am J Prev Cardiol
Malkani K, Zhang R, Sobti N, Zachariah K, Groenendyk J, Purkayastha S, Ying X, Newbury D, Steitieh D, Patel S, Kini V.   +10 more
europepmc   +1 more source

Case Report: Genetic testing reveals Wilson disease with familial hypertriglyceridemia in a 12-year-old boy. [PDF]

Front Pediatr
Wang Y, Wu D, Sun D, Wang J, Wang X.
europepmc   +1 more source